Skip to content
Roboearth – Lifestyle
Author:
Bracco Group
Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging
August 11, 2026
Bracco Receives Approval in Mexico for VUEWAY® injection (gadopiclenol), Advancing Its Commitment to Lower-Dose MRI Across Global Markets
July 21, 2026
Bracco Imaging Earns Second Consecutive EcoVadis Platinum Medal with Record Sustainability Score
July 20, 2026